These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 15201164

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes.
    McKinsey TA, Olson EN.
    J Clin Invest; 2005 Mar; 115(3):538-46. PubMed ID: 15765135
    [Abstract] [Full Text] [Related]

  • 24. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization.
    Luptak I, Balschi JA, Xing Y, Leone TC, Kelly DP, Tian R.
    Circulation; 2005 Oct 11; 112(15):2339-46. PubMed ID: 16203912
    [Abstract] [Full Text] [Related]

  • 25. The creatine kinase energy transport system in the failing mouse heart.
    Lygate CA, Fischer A, Sebag-Montefiore L, Wallis J, ten Hove M, Neubauer S.
    J Mol Cell Cardiol; 2007 Jun 11; 42(6):1129-36. PubMed ID: 17481652
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure.
    Labinskyy V, Bellomo M, Chandler MP, Young ME, Lionetti V, Qanud K, Bigazzi F, Sampietro T, Stanley WC, Recchia FA.
    J Pharmacol Exp Ther; 2007 Apr 11; 321(1):165-71. PubMed ID: 17215446
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Altered intracellular Ca2+ handling in heart failure.
    Yano M, Ikeda Y, Matsuzaki M.
    J Clin Invest; 2005 Mar 11; 115(3):556-64. PubMed ID: 15765137
    [Abstract] [Full Text] [Related]

  • 31. Metabolic energetics and genetics in the heart.
    Taegtmeyer H, Wilson CR, Razeghi P, Sharma S.
    Ann N Y Acad Sci; 2005 Jun 11; 1047():208-18. PubMed ID: 16093498
    [Abstract] [Full Text] [Related]

  • 32. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts.
    Sorokina N, O'Donnell JM, McKinney RD, Pound KM, Woldegiorgis G, LaNoue KF, Ballal K, Taegtmeyer H, Buttrick PM, Lewandowski ED.
    Circulation; 2007 Apr 17; 115(15):2033-41. PubMed ID: 17404155
    [Abstract] [Full Text] [Related]

  • 33. Transcriptional regulation of metabolic processes: implications for cardiac metabolism.
    van Bilsen M, van der Vusse GJ, Reneman RS.
    Pflugers Arch; 1998 Dec 17; 437(1):2-14. PubMed ID: 9817779
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cellular basis for triggered ventricular arrhythmias that occur in the setting of compensated hypertrophy and heart failure: considerations for diagnosis and treatment.
    Antoons G, Oros A, Bito V, Sipido KR, Vos MA.
    J Electrocardiol; 2007 Dec 17; 40(6 Suppl):S8-14. PubMed ID: 17993335
    [Abstract] [Full Text] [Related]

  • 40. Cardiac remodeling and failure: from molecules to man (Part I).
    Fedak PW, Verma S, Weisel RD, Li RK.
    Cardiovasc Pathol; 2005 Dec 17; 14(1):1-11. PubMed ID: 15710285
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.